Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Zaffaroni

Showing results (121-130 of 133) with videos related to

Pageof 14
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 27, 2005
Disease-modifying drugs in childhood-juvenile multiple sclerosis: results of an Italian co-operative studyA Ghezzi, M P Amato, M Capobianco, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|July 3, 2007
Treatment of early-onset multiple sclerosis with intramuscular interferonbeta-1a: long-term resultsA Ghezzi, M P Amato, M Capobianco, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 30, 2008
A pilot trial of low-dose naltrexone in primary progressive multiple sclerosisM Gironi, F Martinelli-Boneschi, P Sacerdote, et al.
Journal of Neurology|July 22, 2021
Risk of multiple sclerosis relapses when switching from fingolimod to cell-depleting agents: the role of washout durationD Ferraro, P Iaffaldano, T Guerra, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|February 20, 2016
Use of herbal remedies by multiple sclerosis patients: a nation-wide survey in ItalyA Loraschi, P Bellantonio, F Bortolon, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|February 4, 2021
Acute and intermediate toxicity of 3-week radiotherapy with simultaneous integrated boost using TomoDirect: prospective series of 287 early breast cancer patientsS Dicuonzo, M C Leonardi, S Raimondi, et al.
Journal of Neurology|June 28, 2018
Two-year real-life efficacy, tolerability and safety of dimethyl fumarate in an Italian multicentre studyGiulia Mallucci, P Annovazzi, S Miante, et al.
Clinical and Translational Radiation Oncology|September 22, 2023
Patients' needs in proton therapy: A survey among ten European facilitiesG C Mazzola, L Bergamaschi, C Pedone, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|September 28, 2011
Recommendations for the management of urinary disorders in multiple sclerosis: a consensus of the Italian Multiple Sclerosis Study GroupA Ghezzi, R Carone, G Del Popolo, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|November 24, 2024
Home-based, computer-assisted cognitive rehabilitation for attention in pediatric onset multiple sclerosis: a randomized, multicenter pilot studyCamilla Masciulli, E Portaccio, B Goretti, et al.
Pageof 14

Showing results (121-130 of 133) with videos related to

Sort By:
Pageof 14
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 27, 2005
Disease-modifying drugs in childhood-juvenile multiple sclerosis: results of an Italian co-operative studyA Ghezzi, M P Amato, M Capobianco, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|July 3, 2007
Treatment of early-onset multiple sclerosis with intramuscular interferonbeta-1a: long-term resultsA Ghezzi, M P Amato, M Capobianco, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 30, 2008
A pilot trial of low-dose naltrexone in primary progressive multiple sclerosisM Gironi, F Martinelli-Boneschi, P Sacerdote, et al.
Journal of Neurology|July 22, 2021
Risk of multiple sclerosis relapses when switching from fingolimod to cell-depleting agents: the role of washout durationD Ferraro, P Iaffaldano, T Guerra, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|February 20, 2016
Use of herbal remedies by multiple sclerosis patients: a nation-wide survey in ItalyA Loraschi, P Bellantonio, F Bortolon, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|February 4, 2021
Acute and intermediate toxicity of 3-week radiotherapy with simultaneous integrated boost using TomoDirect: prospective series of 287 early breast cancer patientsS Dicuonzo, M C Leonardi, S Raimondi, et al.
Journal of Neurology|June 28, 2018
Two-year real-life efficacy, tolerability and safety of dimethyl fumarate in an Italian multicentre studyGiulia Mallucci, P Annovazzi, S Miante, et al.
Clinical and Translational Radiation Oncology|September 22, 2023
Patients' needs in proton therapy: A survey among ten European facilitiesG C Mazzola, L Bergamaschi, C Pedone, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|September 28, 2011
Recommendations for the management of urinary disorders in multiple sclerosis: a consensus of the Italian Multiple Sclerosis Study GroupA Ghezzi, R Carone, G Del Popolo, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|November 24, 2024
Home-based, computer-assisted cognitive rehabilitation for attention in pediatric onset multiple sclerosis: a randomized, multicenter pilot studyCamilla Masciulli, E Portaccio, B Goretti, et al.
Pageof 14